Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
暂无分享,去创建一个
C. Polman | S. Galetta | F. Lublin | M. Hutchinson | E. Havrdová | G. Giovannoni | P. O'Connor | A. Pace | R. Hyde | D. Bates | D. Stefoski | J. Phillips | R. Kim | Paul W. O’Connor